The University of Nevada, Reno School of Medicine

Crack That Case: Individualizing Care in Psoriasis

MD, MBA

Discuss the role of available targeted systemic therapies in individualizing the management of psoriasis. 

Identify targeted systemic therapies that may be better suited for specific patient populations based on demographics, comorbidities, and medical history. 

Recognize patient characteristics that may make the use of certain targeted systemic therapies less favorable. 

Psoriasis is a chronic, immune-mediated inflammatory disease characterized by dysregulated IL-23/IL-17 axis signaling and keratinocyte hyperproliferation, resulting in well-demarcated erythematous plaques with silvery scale. Beyond cutaneous involvement, psoriasis has been linked to systemic inflammation contributing to increased risk of cardiometabolic and other inflammatory comorbidities.

This hub gathers the evidence, expert perspective, and practical insight shaping how psoriasis is understood and treated today, connecting advances in targeted therapy with the everyday decisions required to manage chronic inflammation and systemic risk.

PANP25: Crack That Case: Individualizing Care in Psoriasis

About

Learning Objectives

Intended Audience

Faculty

Accreditation Statement

Credit Designation Statement

Disclosures